2026 NPPES data MOHS-Micrographic Surgery Physician NPI 1487186003
Verify on CMS →

SINA RABI

MOHS-Micrographic Surgery Physician in TARZANA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
660
Medicare Part D claims · 244 beneficiaries · MOHS-Micrographic Surgery Physician avg: 607
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$786.11
27 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SINA RABI is a MOHS-Micrographic Surgery Physician ([object Object]) practicing in TARZANA, California with a Medicare Part D prescribing footprint of 660 claims across 244 beneficiaries — 6% brand-name prescribing . Industry payments of $786.11 across 27 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SINA RABI filed 660 Medicare Part D claims in 2023 across TARZANA, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

SINA RABI practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

SINA RABI at a glance

Quality data not reported

NPI registry status

Active

Issued 04/02/2017

NPI 1487186003

Primary specialty

MOHS-Micrographic Surgery Physician

Niche

1,102 US NPIs in this specialty

Medicare Part D claims

660 9% vs specialty avg

2023 prescription claims

Specialty avg: 607

Specialty distribution in California

How MOHS-Micrographic Surgery Physician compares to other specialties among California providers

California providers

MOHS-Micrographic Surgery Physician share within California

1. MOHS-Micrographic Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
MOHS-Micrographic Surgery Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — MOHS-Micrographic Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
MOHS-Micrographic Surgery Physician ABMS/AOA estimate

Est. board-certified rate (MOHS-Micrographic Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (MOHS-Micrographic Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SINA RABI is a MOHS-Micrographic Surgery Physician provider practicing in TARZANA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1487186003. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SINA RABI appears in the CMS NPPES registry as a MOHS-Micrographic Surgery Physician provider at 19100 VENTURA BLVD, TARZANA, CA, 91356, with a listed phone of (818) 343-0101. NPI 1487186003 was issued on 04/02/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RABI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 660 prescription claims written by this provider, covering 244 Medicare beneficiaries and totaling roughly $84K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

MOHS-Micrographic Surgery Physician is a narrow specialty nationwide, with 1,102 enrolled providers across 52 states and an average of 607 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

19100 VENTURA BLVD
TARZANA, CA 91356

Provider Details

NPI 1487186003
Specialty MOHS-Micrographic Surgery Physician
Gender Male
NPI Issued 04/02/2017

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SINA RABI. Source: openpaymentsdata.cms.gov.

Total received

$786

Largest payer

Incyte Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SINA RABI. To verify SINA RABI's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SINA RABI — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 660 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

660
Total Claims
$84K
Total Drug Cost
244
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
720
Total Day Supply
17,954
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$52K
Generic Drug Cost
$32K
Antibiotic Claims
60

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
1.47
Gender Split
44% female / 56% male
Age Distribution
<65: 18, 65-74: 125, 75-84: 72, 85+: 29

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketoconazole
129
Clobetasol Propionate
113
Triamcinolone Acetonide
77
Mupirocin
44
Tacrolimus
42
Hydrocortisone
34
Cephalexin
29
Doxycycline Monohydrate
26
Clindamycin Phosphate
23
Fluocinolone Acetonide
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

MOHS-Micrographic Surgery Physician Overview

How SINA RABI fits within the MOHS-Micrographic Surgery Physician landscape nationally.

1,102
MOHS-Micrographic Surgery Physician Providers in US
52
States with MOHS-Micrographic Surgery Physician
607
Avg Claims per Provider

SINA RABI's 660 claims are above the specialty average of 607.

Nearby MOHS-Micrographic Surgery Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as RABI.

Compare MOHS-Micrographic Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SINA RABI's specialty?
SINA RABI specializes in MOHS-Micrographic Surgery Physician and practices in TARZANA, California.
How much does SINA RABI prescribe under Medicare Part D?
In 2023, SINA RABI wrote 660 Medicare Part D claims totaling $84K in drug costs for 244 beneficiaries.
Where is SINA RABI located?
SINA RABI is located at 19100 VENTURA BLVD, TARZANA, CA, 91356. Phone: (818) 343-0101.
What is SINA RABI's NPI number?
SINA RABI's National Provider Identifier (NPI) is 1487186003, issued on 04/02/2017.
Does SINA RABI prescribe more brand-name or generic drugs?
SINA RABI's prescribing is 6% brand-name and 94% generic drugs by claim count, with $52K in brand drug costs.
How many MOHS-Micrographic Surgery Physician providers are there in the US?
There are 1,102 MOHS-Micrographic Surgery Physician providers across 52 states in the US. The average MOHS-Micrographic Surgery Physician provider writes 607 Medicare Part D claims per year.
What drugs does SINA RABI prescribe most often?
Based on 2023 Medicare Part D data, SINA RABI's most frequently prescribed drugs include Ketoconazole, Clobetasol Propionate, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SINA RABI accept Medicare?
SINA RABI appears in CMS Medicare data with 660 Part D claims and 244 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SINA RABI's credentials?
SINA RABI's NPI is 1487186003. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology